169 related articles for article (PubMed ID: 35074273)
1. Impact of peri-transplant RBC transfusion and ABO incompatibility on acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.
Sever T; Kirkiz S; Kaya Z; Kocak U
Transfus Apher Sci; 2022 Jun; 61(3):103352. PubMed ID: 35074273
[TBL] [Abstract][Full Text] [Related]
2. Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD; Koff JL; Khoury HJ; Langston AA; Zimring JC; Roback JD; Giver CR
Biol Blood Marrow Transplant; 2018 May; 24(5):973-982. PubMed ID: 29307717
[TBL] [Abstract][Full Text] [Related]
3. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
Wang Z; Sorror ML; Leisenring W; Schoch G; Maloney DG; Sandmaier BM; Storb R
Br J Haematol; 2010 Apr; 149(1):101-10. PubMed ID: 20067562
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
[TBL] [Abstract][Full Text] [Related]
5. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
[TBL] [Abstract][Full Text] [Related]
6. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
[TBL] [Abstract][Full Text] [Related]
7. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
[TBL] [Abstract][Full Text] [Related]
8. ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies.
Chen Y; Wan X; Cao Y; Wang H; Han D; Zhang Y; Yao W; Song K; Fan Q; Zhu X; Sun Z; Liu H
Blood Transfus; 2022 Mar; 20(2):156-167. PubMed ID: 34369864
[TBL] [Abstract][Full Text] [Related]
9. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
Atay D; Erbey F; Akcay A; Ozturk G
Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
[TBL] [Abstract][Full Text] [Related]
10. Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia.
Ma YR; Wang WJ; Cheng YF; Zhang YY; Mo XD; Han TT; Wang FR; Yan CH; Sun YQ; Chen YH; Wang JZ; Tang FF; Han W; Wang Y; Zhang XH; Huang XJ; Xu LP
Bone Marrow Transplant; 2020 Jun; 55(6):1068-1075. PubMed ID: 31932654
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ABO-Incompatibility on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation].
Yang BB; Gan YF; Chen P; Chen Y; Yu K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):535-540. PubMed ID: 28446307
[TBL] [Abstract][Full Text] [Related]
12. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
[TBL] [Abstract][Full Text] [Related]
13. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
14. [Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation].
Bao L; Huang XJ; Liu KY; Xu LP; Chen H; Zhang YC; Chen YH; Han W; Lu DP
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):126-9. PubMed ID: 15841137
[TBL] [Abstract][Full Text] [Related]
15. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
[TBL] [Abstract][Full Text] [Related]
16. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
[TBL] [Abstract][Full Text] [Related]
17. ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation.
Yang N; Guan L; Liu Z; Ding Y; Zhu C; Luo L; Wang F; Fang S; Gao Z; Gu Z; Gao C
Ann Transplant; 2019 Jun; 24():350-358. PubMed ID: 31197126
[TBL] [Abstract][Full Text] [Related]
18. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
Badros A; Tricot G; Toor A; Morris C; Guo C; Munshi N; Barlogie B; Cottler-Fox M
Transfusion; 2002 Feb; 42(2):205-9. PubMed ID: 11896336
[TBL] [Abstract][Full Text] [Related]
19. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Wang S
Transfusion; 2019 Nov; 59(11):3371-3385. PubMed ID: 31599972
[TBL] [Abstract][Full Text] [Related]
20. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.
Worel N; Kalhs P; Keil F; Prinz E; Moser K; Schulenburg A; Mitterbauer M; Mannhalter C; Mayr WR; Schwarzinger I; Höcker P; Lechner K; Greinix HT
Transfusion; 2003 Aug; 43(8):1153-61. PubMed ID: 12869124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
